Our Mentors

All the projects selected for the programme will be assigned a mentor, a person responsible for advising on drawing up the Valorization and Business Plans and throughout the course of the programme in order to actively monitor the project and guide its evolution.

Meet our mentors

Member of the Board

Raj Airey


CEO at Aelix Therapeutics

José Luis Cabero

Aelix Therapeutics & Symbiokraft

Research Director

Clara Campàs

Kern Pharma SL


Andrés G. Fernández

Ferrer Advanced Biotherapeutics

ICREA Research Professor and Co-founder

Roger Gomis

Inbiomotion SL

Founder & CSO

Tamara Maes

Oryzon Genomics

Deputy Director of Innovation. Head of Health Technology Assessment Unit

Laura Sampietro

Hospital Clínic de Barcelona

Global Product Marketing Manager

Raúl Zurita

B. Braun España

Specialised Training

Four weeks to improve your projecte and valorisation plan

Project Management week

From 12 to 16 December 2016 (dates to be confirmed).

Improve the planning and monitoring of the valorisation and commercialisation plans, implement efficiency.

Tech Transfer & Valorization week

From 9 to 13 January 2017 (dates to be confirmed).

Tools to improve the corresponding valorisation plan; product development (technical assessment), intellectual property legislation (IP assessment), industrial development and pitch day.

Commercialization week

From 6 to 10 February 2017 (dates to be confirmed).

Provide participants with the tools needed to improve their commercialisation plan; financial planning, finance, regulatory advice, licensing, marketing and sales strategy, etc.

Financing week

From 6 to 10 March 2017 (dates to be confirmed).

Basic tools and practical knowledge to hold negotiations in the Health & Life Sciences sector. Diverse financing opportunities and venture capital strategy

Expert Advice

Access to an extensive directory of national and international specialists

12 hours of consultancy in various areas:
  • Drug development
  • Medical device development
  • Diagnosis development
  • Drug discovery
  • Preclinical development
  • Medicinal and compounding chemistry
  • Drug marketing
  • Medical device marketing
  • Diagnosis marketing
  • Computer-assisted tools
  • Formulation and administration
  • Prototyping and design
  • Funding
  • IP, licensing and legal issues
  • Transfer and evaluation
  • Regulatory aspects
  • Market research
  • Entrepreneurs